|
 |
 |
 |
 |
 |
 |
 |
| Event homepage |
| Programme in full |
| Speakers |
| 4 reasons to come |
| Our advisory board |
| Free report |
| Podcasts |
Keynote Sessions
|
This prestigious plenary session, you will hear from the innovators, leaders and key stakeholders to show you where sales and marketing in pharma is heading and provide you with business insights and new ideas for developing strategies for the future.
This one-of-its-kind keynote session will look at:
Key Stakeholders and New Customers: As the European healthcare environment shifts, who else should you be considering as a customer and how do you go about delivering strategies that meet their needs
New and innovative ideas from outside of pharma: Hear from a senior sales and marketing expert from a leading brand in FMCG on how they deliver customer relationship strategies
Look into the future: Gain a unique insight into what you need to be planning for and how the future looks for healthcare in Europe
Keynote Presentations (1 April)
From content to care the future of pharma's value propositions The pharma business model has traditionally focused on content e.g. producing and selling products. Generic competition, lack of NMEs, patent expiries and strong focus on value based pricing is forcing pharma to focus on new business models. One obvious solution is to produce evidence based product packets rather than sole products. This will turn the focus from product to service or from content to care. In essence this will contribute to a sustainable, responsible and rational pharma marketing approach for the future. In this exclusive presentation you will: Hear unique research on how you can deliver a more customer, servicerelated product to your customers Find out how this approach to your products will increase access and health outcomes and drive market share Claus Moldrup, Associate Professor, University of Copenhagen , Visiting Professor, INSEAD
Customer Viewpoint: Find out how to add more value to your customer communications and develop strong bonds with healthcare
Chris Town, former Chief Executive, Greater Peterborough Primary Care Partnership
|
Pharma SFE 2.0 How to go beyond more-of-the-same' processes, IT, and standard solutions and engage in true business transformation Five key transformations still in the to-do list How to jump from me-too evolution to true organizational leadership Overcoming Pharma change management motto: change is great, you go first' The emperor has no clothes' and your CRM has no customers: is customer-centrism in pharma a myth? Seven deadly fallacies in pharma SFE: how business transformation is impaired by disconnected structures, processes and behaviours Leandro Herrero, CEO, The Chalfont Project
|
Lunch |
Consumer power: How will consumer power push and influence how pharma operates Hear unique information on consumer trends from Europe on how unless you recognise these trends, you could be devaluing your business Find out how you can partner with consumers and create a better reputation for your business Hear how consumers have lead other industries and why despite DTC regulations, you need to be listening to this powerful group
Dr Jeff French, Director, National Social Marketing Centre
|
Advisory Board Super Panel Session: How will the big pharma business model evolve in the next 5 years? Hear different views on how the pharma commercial model will shift in the coming years & things you need to start planning for now to be ahead of the game Debate what the rep of the future will look like. Medical advisor? Educational rep? Will there be reps at all? Is the pharma commercial model really broken? Does it really need fixing? How much more has to happen before radical changes really start being made? Trust and reputation how can pharma rebuild it's image and garner trust with customers This 90 minute super panel session will give you the chance to probe the minds of the pharma industries leading executives and find out how they believe the industry will change and what they are doing already to prepare their companies for the future.
Advisory Board members participating: Len Starnes, Global Head e-Business, Bayer-Schering Dudley Ferguson , Managing Director, Astellas UK Ian Talmage, VP Global Marketing, Bayer-Schering
Plus special guests: Roy Lilley, independent health policy analyst, writer and broadcaster on health and social issues Stewart Adkins, Director, Stewart Adkins Advisors Limited (formerly Pharmaceutical Equity Research, Lehman Brothers )
|
 |
